Pharmacological methods for blood stabilization in the extracorporeal circuit (review of literature)
We summarize the possible benefits and risks of using various anticoagulants during hemoperfusion. Clotting in the extracorporeal circuit can lead to a decrease in the effectiveness of therapy, additional workload, risk to the patient and economic losses. At the same time, relatively excessive ant...
Saved in:
| Main Authors: | M. S. Mendibaev, S. E. Rabotinsky |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2023-02-01
|
| Series: | Вестник анестезиологии и реаниматологии |
| Subjects: | |
| Online Access: | https://www.vair-journal.com/jour/article/view/758 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anticoagulation and monitoring in pediatric extracorporeal membrane oxygenation
by: Jamie Weller, et al.
Published: (2018-12-01) -
The factor XIa antibody osocimab strongly inhibits clotting in extracorporeal circuits with human blood and in baboons
by: Eslam Samaha, et al.
Published: (2025-05-01) -
Fresh frozen plasma: A solution to heparin resistance during extracorporeal membrane oxygenation (ECMO)
by: Fayaz Mohammed Khazi, et al.
Published: (2018-12-01) -
Specific Changes in Hemostasis System Parameters during Extracorporeal Membrane Oxygenation in Patients with a Novel Coronavirus Infection
by: S. V. Zhuravel, et al.
Published: (2022-08-01) -
Sorbents for Extracorporeal Removal of Toxic Substances and Molecules with Adverse Biological Activity (Review)
by: A. S. Morozov, et al.
Published: (2017-01-01)